These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 23072902)

  • 1. Translational research challenges: finding the right animal models.
    Prabhakar S
    J Investig Med; 2012 Dec; 60(8):1141-6. PubMed ID: 23072902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models of human disease: challenges in enabling translation.
    McGonigle P; Ruggeri B
    Biochem Pharmacol; 2014 Jan; 87(1):162-71. PubMed ID: 23954708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The translatability of animal models for clinical development: biomarkers and disease models.
    Wendler A; Wehling M
    Curr Opin Pharmacol; 2010 Oct; 10(5):601-6. PubMed ID: 20542730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rodent models for human diseases.
    Vandamme TF
    Eur J Pharmacol; 2015 Jul; 759():84-9. PubMed ID: 25823811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preface to the special issue "Novel pharmaconeurogenetic approaches arising from progress in translational genetics".
    Renger JJ; Kern JT
    J Neurogenet; 2011 Dec; 25(4):117-9. PubMed ID: 22074379
    [No Abstract]   [Full Text] [Related]  

  • 6. Reverse translation of failed treatments can help improving the validity of preclinical animal models.
    't Hart BA
    Eur J Pharmacol; 2015 Jul; 759():14-8. PubMed ID: 25823810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular pharmacotherapy: Innovation stuck in translation.
    Rongen GA; Wever KE
    Eur J Pharmacol; 2015 Jul; 759():200-4. PubMed ID: 25814253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory acceptance of animal models of disease to support clinical trials of medicines and advanced therapy medicinal products.
    Cavagnaro J; Silva Lima B
    Eur J Pharmacol; 2015 Jul; 759():51-62. PubMed ID: 25814257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of Huntington's disease for translation to the clinic: best practices.
    Menalled L; Brunner D
    Mov Disord; 2014 Sep; 29(11):1375-90. PubMed ID: 25216369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why clinical translation cannot succeed without failure.
    London AJ; Kimmelman J
    Elife; 2015 Nov; 4():e12844. PubMed ID: 26599839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The translational value of non-human primates in preclinical research on infection and immunopathology.
    't Hart BA; Bogers WM; Haanstra KG; Verreck FA; Kocken CH
    Eur J Pharmacol; 2015 Jul; 759():69-83. PubMed ID: 25814254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The next step in translational research: lessons learned from the first preclinical randomized controlled trial.
    Llovera G; Liesz A
    J Neurochem; 2016 Oct; 139 Suppl 2():271-279. PubMed ID: 26968835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational paradigms in pharmacology and drug discovery.
    Mullane K; Winquist RJ; Williams M
    Biochem Pharmacol; 2014 Jan; 87(1):189-210. PubMed ID: 24184503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational research in spinal cord injury: a survey of opinion from the SCI community.
    Kwon BK; Hillyer J; Tetzlaff W
    J Neurotrauma; 2010 Jan; 27(1):21-33. PubMed ID: 19751098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. We can treat Alzheimer's disease successfully in mice but not in men: failure in translation? A perspective.
    Windisch M
    Neurodegener Dis; 2014; 13(2-3):147-50. PubMed ID: 24401335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety, efficacy and regulatory triangle in drug development: Impact for animal models and the use of animals.
    van Meer PJ; Graham ML; Schuurman HJ
    Eur J Pharmacol; 2015 Jul; 759():3-13. PubMed ID: 25818943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miniature Swine for Preclinical Modeling of Complexities of Human Disease for Translational Scientific Discovery and Accelerated Development of Therapies and Medical Devices.
    Schomberg DT; Tellez A; Meudt JJ; Brady DA; Dillon KN; Arowolo FK; Wicks J; Rousselle SD; Shanmuganayagam D
    Toxicol Pathol; 2016 Apr; 44(3):299-314. PubMed ID: 26839324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and molecular biomarkers in translational animal models for neuropsychiatric disorders.
    Sarnyai Z; Alsaif M; Bahn S; Ernst A; Guest PC; Hradetzky E; Kluge W; Stelzhammer V; Wesseling H
    Int Rev Neurobiol; 2011; 101():203-38. PubMed ID: 22050853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational immunologic safety evaluation: a perspective.
    Descotes J
    J Immunotoxicol; 2013; 10(1):83-9. PubMed ID: 22967109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine networks in multiple sclerosis: lost in translation.
    Codarri L; Fontana A; Becher B
    Curr Opin Neurol; 2010 Jun; 23(3):205-11. PubMed ID: 20442570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.